Therapeutic agent for inflammatory bowel disease
US7820686B2 · kind B2 · utility
0Cited by
2References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 12, 2007 |
| Grant date | Oct 26, 2010 |
| Priority date | — |
| Expiry date | Apr 12, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a method of treating an inflammatory bowel disease such as ulcerative colitis or Crohn's disease, which comprises administering an effective amount of the therapeutic agent 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione, or a pharmaceutically acceptable salt thereof, to a patient with inflammatory bowel disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.